Document is current
Any future updates will be listed below
-
Authors
Kunii, Tomohisa
Usui, Isao https://orcid.org/0000-0002-4720-4882
Jojima, Teruo
Shimizu, Masanori
Kase, Masato
Sakurai, Shintaro
Tomaru, Takuya
Iijima, Toshie
Aso, Yoshimasa
- License Information
-
More Information
Article History
Received: 17 October 2023
Accepted: 25 January 2024
First Online: 26 February 2024
Declarations
:
: Yoshimasa Aso received honoraria from Daiichi Sankyo, Tanabe Mitsubishi, Sumitomo Pharma, and Novo Nordisk as lecture fees. Tomohisa Kunii, Isao Usui, Teruo Jojima, Masanori Shimizu, Masato Kase, Shintaro Sakurai, Takuya Tomaru, and Toshie Iijima declare that they have no conflict of interest.
: The study with human subjects was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) and in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
: Written informed consent was obtained from all participants. The study was approved by the institutional review board of Dokkyo Medical University (Approval number R-5-4, date 20/12/2017) and registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000041917).
